PeproTech Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hao, H.
Right arrow Articles by Kaplan, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hao, H.
Right arrow Articles by Kaplan, A. M.
(Journal of Leukocyte Biology. 2000;68:515-521.)
© 2000 by Society for Leukocyte Biology

Bleomycin-induced pulmonary fibrosis is independent of eosinophils

Huiqing Hao, Donald A. Cohen, C. Darrell Jennings, J. Scott Bryson and Alan M. Kaplan

Department of Microbiology and Immunology, the Graduate Center for Toxicology, and the Department of Internal Medicine, University of Kentucky, College of Medicine, Lexington, Kentucky

Correspondence: Dr. Alan M. Kaplan, Department of Microbiology and Immunology, University of Kentucky, College of Medicine, 800 Rose Street, Room MS 411, Lexington, KY 40536-0084. E-mail: akaplan{at}pop.uky.edu

Eosinophils have been shown to increase in tissues during many fibrotic conditions and consequently have been suggested to contribute to the development of fibrosis. This study tested the hypothesis that eosinophils are essential in the development of lung fibrosis in mice in response to bleomycin (BLM). Anti-IL-5 antibody was administered intraperitoneally into mice 2 h prior to endotracheal BLM inoculation and thereafter, every other day. Lung eosinophilia was evaluated by measurement of eosinophil peroxidase activity and confirmed by eosinophil counts in histologic sections. Lung fibrosis was evaluated by hydroxyproline content and confirmed by collagen staining in histological sections. Results demonstrated that BLM induced pronounced lung eosinophilia, which was maximal 7 days after BLM treatment and remained elevated through day 14, in C57Bl/6 SCID mice and CBA/J mice. In contrast, eosinophilia was a minor component in the lungs of wildtype C57Bl/6 mice after BLM treatment, although lung fibrosis developed similarly in all three strains of mice. Treatment with anti-IL-5 completely abrogated eosinophilia but failed to block pulmonary fibrosis induced by BLM in all mouse strains, including C57Bl/6 SCID, wildtype C57Bl/6 mice, and CBA/J mice. Analysis of cytokine mRNA by RNase-protection assay in C57Bl/6 SCID mice indicated that BLM treatment caused enhanced expression of the cytokines, TNF-{alpha}, and IL-6 at days 3, 7, and 14 post-BLM inoculation, regardless of whether eosinophils were depleted by anti-IL-5. Finally, the importance of eosinophils in lung fibrosis was examined in IL-5 gene knockout mice (IL-5tm1Kopf). BLM treatment induced significant lung fibrosis in IL-5 knockout mice in the absence of eosinophilia. These findings indicate that eosinophils are not an absolute requirement for BLM-induced pulmonary fibrosis in the mouse.

Key Words: lung eosinophilia • cytokines • knockout mice




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Mozaffarian, A. W. Brewer, E. S. Trueblood, I. G. Luzina, N. W. Todd, S. P. Atamas, and H. A. Arnett
Mechanisms of Oncostatin M-Induced Pulmonary Inflammation and Fibrosis
J. Immunol., November 15, 2008; 181(10): 7243 - 7253.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. B. Wallach-Dayan, R. Golan-Gerstl, and R. Breuer
Evasion of myofibroblasts from immune surveillance: A mechanism for tissue fibrosis
PNAS, December 18, 2007; 104(51): 20460 - 20465.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. van den Brule, J. Heymans, X. Havaux, J.-C. Renauld, D. Lison, F. Huaux, and O. Denis
Profibrotic Effect of IL-9 Overexpression in a Model of Airway Remodeling
Am. J. Respir. Cell Mol. Biol., August 1, 2007; 37(2): 202 - 209.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Arras, J. Louahed, J.-F. Heilier, M. Delos, F. Brombacher, J.-C. Renauld, D. Lison, and F. Huaux
IL-9 Protects against Bleomycin-Induced Lung Injury: Involvement of Prostaglandins
Am. J. Pathol., January 1, 2005; 166(1): 107 - 115.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Huaux, T. Liu, B. McGarry, M. Ullenbruch, Z. Xing, and S. H. Phan
Eosinophils and T Lymphocytes Possess Distinct Roles in Bleomycin-Induced Lung Injury and Fibrosis
J. Immunol., November 15, 2003; 171(10): 5470 - 5481.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. Chakrabarti, K. S. Kobayashi, R. A. Flavell, C. B. Marks, K. Miyake, D. R. Liston, K. T. Fowler, F. S. Gorelick, and N. W. Andrews
Impaired membrane resealing and autoimmune myositis in synaptotagmin VII-deficient mice
J. Cell Biol., August 18, 2003; 162(4): 543 - 549.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Ghosh, T. Mendoza, L. A. Ortiz, G. W. Hoyle, C. D. Fermin, A. R. Brody, M. Friedman, and G. F. Morris
Bleomycin Sensitivity of Mice Expressing Dominant-Negative p53 in the Lung Epithelium
Am. J. Respir. Crit. Care Med., September 15, 2002; 166(6): 890 - 897.
[Abstract] [Full Text]